Honest writing about modern weight-loss medicine.

SkinnyDrugs is an independent editorial publication covering GLP-1 medications — Wegovy, Ozempic, Mounjaro, and the broader category of semaglutide and tirzepatide. We are not a telehealth company. We don't sell medication. We don't run an affiliate program.

What we cover

The science of GLP-1, what to expect on each medication week by week, common and uncommon side effects, nutrition and training that support long-term results, mental and emotional shifts during weight loss, and how to track progress beyond a single number on a scale.

How we write

Every article is written in plain English, reviewed against current peer-reviewed research, and edited to remove the things that make health writing untrustworthy: hype, miracle claims, fake transformations, and pressure to buy something.

Editorial principles

• Education first. Nothing on this site is medical advice.
• No affiliate links inside article content.
• Real names and credentials on every byline.
• Updated dates that reflect actual revisions, not SEO games.

Get in touch

Tips, corrections, or research suggestions are always welcome. Reach the editorial team on the contact page.